MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%

Sector Heatmap

Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%

NPCE — Neuropace, Inc. Common Stock

Nasdaq

Neuropace, Inc. Common Stock

CompareBack to Screener
$12.67
-0.55(-4.16%)
O
13.38
H
13.38
L
12.66
V
81.71K
⏱️ End-of-day dataAs of Oct 6, 2026

Chart

About NPCE

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateApr 22, 2021
Employees220
Stock ExchangeNasdaq
Ticker SymbolNPCE

Key Financial Statistics

Market Cap$435.92M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$9.22 - $19.60
52-Week Avg Volume196.8K
VWAP$12.92
Transactions2,735
Total Recorded Bars1,371 days